The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Iron Metabolism in Cancer
Open accessAbstract
Demanded as an essential trace element that supports cell growth and basic functions, iron can be harmful and cancerogenic though. By exchanging between its different oxidized forms, iron overload induces free radical formation, lipid peroxidation, DNA, and protein damages, leading to carcinogenesis or ferroptosis. Iron also plays profound roles in modulating tumor microenvironment and metastasis, maintaining genomic stability and controlling epigenetics. in order to meet the high requirement of iron, neoplastic cells have remodeled iron metabolism pathways, including acquisition, storage, and efflux, which makes manipulating iron homeostasis a considerable approach for cancer therapy. Several iron chelators and iron oxide nanoparticles (IONPs) has recently been developed for cancer intervention and presented considerable effects. This review summarizes some latest findings about iron metabolism function and regulation mechanism in cancer and the application of iron chelators and IONPs in cancer diagnosis and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, Z. L., Duan, J., Wang, J., Liu, Q., Shang, R., Yang, X., Lu, P., Xia, C., Wang, L. Q., & Dou, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s155537 · Cited by 81
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621
Role of GPX4 in ferroptosis and its pharmacological implication
Seibt, T. M., Proneth, B., & Conrad, M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.014 · Cited by 1,520
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Iron homeostasis in host defence and inflammation
Ganz, T., & Nemeth, E. (2015) · Nature Reviews Immunology · doi:10.1038/nri3863 · Cited by 843 · cited 1×
“Inflammatory stressors in the tumor microenvironment play a critical role in controlling iron metabolism and homeostatic pathway [122].”
BackgroundNFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis
Alvarez, S. W., Sviderskiy, V. O., Terzi, E. M., Papagiannakopoulos, T., Moreira, A. L., Adams, S., Sabatini, D. M., Birsoy, K., & Possemato, R. (2017) · Nature · doi:10.1038/nature24637 · Cited by 787
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Shen, Z., Song, J., Yung, B. C., Zhou, Z., Wu, A., & Chen, X. (2018) · Advanced Materials · doi:10.1002/adma.201704007 · Cited by 740
The tumor suppressor protein p53 and the ferroptosis network
Kang, R., Kroemer, G., & Tang, D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.074 · Cited by 698
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels, T. R., Delgado, T., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 518
Iron Metabolism and the IRE/IRP Regulatory System: An Update
PANTOPOULOS, K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.001 · Cited by 512
Identification of the receptor scavenging hemopexin-heme complexes
Hvidberg, V., Maniecki, M. B., Jacobsen, C., Højrup, P., Møller, H. J., & Moestrup, S. K. (2005) · Blood · doi:10.1182/blood-2005-03-1185 · Cited by 473
The role of iron in cell cycle progression and the proliferation of neoplastic cells
Le, N. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00068-9 · Cited by 453
The Role of Ferroptosis in Cancer Development and Treatment Response
Lu, B., Chen, X. B., Ying, M. D., He, Q. J., Cao, J., & Yang, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00992 · Cited by 444 · cited 1×
“Ferroptosis has been reported to be able to inhibit some cancer types, such as hepatocellular carcinoma (HCC), pancreatic carcinoma, breast cancer, and prostate cancer [99].”
BackgroundHuang, X. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.08.023 · Cited by 444
Structural studies on 2-oxoglutarate oxygenases and related double-stranded β-helix fold proteins
Clifton, I. J., McDonough, M. A., Ehrismann, D., Kershaw, N. J., Granatino, N., & Schofield, C. J. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.01.024 · Cited by 441
Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N., & Torti, F. M. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051732 · Cited by 426
Lipocalin 2 protects from inflammation and Tumorigenesis associated with gut microbiota alterations
Moschen, A. R., Gerner, R. R., Wang, J., Klepsch, V., Adolph, T. E., Reider, S. J., Hackl, H., Pfister, A., Schilling, J., Moser, P. L., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.03.007 · Cited by 375
The IRP/IRE system in vivo: insights from mouse models
Wilkinson, N., & Pantopoulos, K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00176 · Cited by 366
Scara5 Is a Ferritin Receptor Mediating Non-Transferrin Iron Delivery
Li, J. Y., Paragas, N., Ned, R. M., Qiu, A., Viltard, M., Leete, T., Drexler, I. R., Chen, X., Sanna-Cherchi, S., Mohammed, F., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2008.12.002 · Cited by 353
Targeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352
Oxidative stress alters global histone modification and DNA methylation
Niu, Y., DesMarais, T. L., Tong, Z., Yao, Y., & Costa, M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.01.028 · Cited by 345
Iron overloaded polarizes macrophage to proinflammation phenotype through ROS/acetyl‐p53 pathway
Zhou, Y., Que, K., Zhang, Z., Yi, Z. J., Zhao, P. X., You, Y., Gong, J., & Liu, Z. (2018) · Cancer Medicine · doi:10.1002/cam4.1670 · Cited by 336
Overview of Lactoferrin as a Natural Immune Modulator
Legrand, D. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.02.071 · Cited by 296
Ferritinophagy/ferroptosis: Iron‐related newcomers in human diseases
Tang, M., Chen, Z., Wu, D., & Chen, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26954 · Cited by 290
Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions
Dignass, A., Farrag, K., & Stein, J. (2018) · International Journal of Chronic Diseases · doi:10.1155/2018/9394060 · Cited by 286
Redox signaling and cancer: The role of “labile” iron
Galaris, D., Skiada, V., & Barbouti, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.038 · Cited by 284
Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer
Tang, X. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.024 · Cited by 276 · cited 2×
“FTL gathered in cancer lesions to promote proliferation is potentially taken up from plasma via specific receptors, such as scavenger receptor class A member-5 (SCARA5) from the release of TAMs, particularly in response to pro-inflammatory cytokines [140,144].”
BackgroundZhu, L., Zhou, Z., Mao, H., & Yang, L. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0316 · Cited by 267
Connections between TET proteins and aberrant DNA modification in cancer
Huang, Y., & Rao, A. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.07.005 · Cited by 264
The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice
Castoldi, M., Vujic Spasic, M., Altamura, S., Elmén, J., Lindow, M., Kiss, J., Stolte, J., Sparla, R., D’Alessandro, L. A., Klingmüller, U., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44883 · Cited by 247
Xue, X., Ramakrishnan, S. K., Weisz, K., Triner, D., Xie, L., Attili, D., Pant, A., Győrffy, B., Zhan, M., Carter-Su, C., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.015 · Cited by 245
White, C., Yuan, X., Schmidt, P. J., Bresciani, E., Samuel, T. K., Campagna, D., Hall, C., Bishop, K., Calicchio, M. L., Lapierre, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.005 · Cited by 241
Tuning Cell Cycle Regulation with an Iron Key
Yu, Y., Kovacevic, Z., & Richardson, D. R. (2007) · Cell Cycle · doi:10.4161/cc.6.16.4603 · Cited by 232
Modulation of iron transport proteins in human colorectal carcinogenesis
Brookes, M. J., Hughes, S., Turner, F. E., Reynolds, G., Sharma, N., Ismail, T., Berx, G., McKie, A. T., Hotchin, N., Anderson, G. J., et al. (2006) · Gut · doi:10.1136/gut.2006.094060 · Cited by 226
Non-transferrin-bound iron transporters
Knutson, M. D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.413 · Cited by 221
The iron metabolism of neoplastic cells: Alterations that facilitate proliferation?
Kwok, J. C., & Richardson, D. R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00213-x · Cited by 215
STEAP Proteins: From Structure to Applications in Cancer Therapy
Gomes, I. M., Maia, C. J., & Santos, C. R. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0281 · Cited by 211
Hong, S. H., Lee, D.-H., Lee, Y.-S., Jo, M. J., Jeong, Y. A., Kwon, W. T., Choudry, H. A., Bartlett, D. L., & Lee, Y. J. (2017) · Oncotarget · doi:10.18632/oncotarget.23046 · Cited by 209
Role of ferritin alterations in human breast cancer cells
Shpyleva, S. I., Tryndyak, V. P., Kovalchuk, O., Starlard-Davenport, A., Chekhun, V. F., Beland, F. A., & Pogribny, I. P. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0849-4 · Cited by 206
An iron regulatory gene signature predicts outcome in breast cancer
Miller, L. D., Coffman, L. G., Chou, J. W., Black, M. A., Bergh, J., D'Agostino, R., Torti, S. V., & Torti, F. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1870 · Cited by 202
p53 genes function to restrain mobile elements
Wylie, A., Jones, A. E., D'Brot, A., Lu, W.-J., Kurtz, P., Moran, J. V., Rakheja, D., Chen, K. S., Hammer, R. E., Comerford, S. A., et al. (2016) · Genes & Development · doi:10.1101/gad.266098.115 · Cited by 198
NEET Proteins: A New Link Between Iron Metabolism, Reactive Oxygen Species, and Cancer
Mittler, R., Darash-Yahana, M., Sohn, Y. S., Bai, F., Song, L., Cabantchik, I. Z., Jennings, P. A., Onuchic, J. N., & Nechushtai, R. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7502 · Cited by 186
Novel Chelators for Cancer Treatment: Where Are We Now?
Merlot, A. M., Kalinowski, D. S., & Richardson, D. R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4540 · Cited by 185
Cell iron status influences macrophage polarization
Agoro, R., Taleb, M., Quesniaux, V. F. J., & Mura, C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196921 · Cited by 177
Does excess iron play a role in breast carcinogenesis? an unresolved hypothesis
Kabat, G. C., & Rohan, T. E. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9058-9 · Cited by 173
Alarifi, S., Ali, D., Alkahtani, S., & Alhader, M. S. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-9972-0 · Cited by 170
A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells
El Hout, M., Dos Santos, L., Hamaï, A., & Mehrpour, M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.009 · Cited by 168
Iron Oxide Nanoparticles-Based Vaccine Delivery for Cancer Treatment
Zhao, Y., Zhao, X., Cheng, Y., Guo, X., & Yuan, W. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01103 · Cited by 165
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy
Busti, F., Marchi, G., Ugolini, S., Castagna, A., & Girelli, D. (2018) · Pharmaceuticals · doi:10.3390/ph11040094 · Cited by 165
Iron induces anti-tumor activity in tumor-associated macrophages
Costa da Silva, M., Breckwoldt, M. O., Vinchi, F., Correia, M. P., Stojanovic, A., Thielmann, C. M., Meister, M., Muley, T., Warth, A., Platten, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01479 · Cited by 164
Targeting cancer by binding iron: Dissecting cellular signaling pathways
Lui, G. Y. L., Kovacevic, Z., Richardson, V., Merlot, A. M., Kalinowski, D. S., & Richardson, D. R. (2015) · Oncotarget · doi:10.18632/oncotarget.4349 · Cited by 161
Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities
Zhang, C., & Zhang, F. (2014) · Protein & Cell · doi:10.1007/s13238-014-0119-z · Cited by 159
A role for divalent metal transporter (DMT1) in mitochondrial uptake of iron and manganese
Wolff, N. A., Garrick, M. D., Zhao, L., Garrick, L. M., Ghio, A. J., & Thévenod, F. (2018) · Scientific Reports · doi:10.1038/s41598-017-18584-4 · Cited by 151
Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2
Yang, X., Park, S., Chang, H., Shapiro, J. S., Vassilopoulos, A., Sawicki, K. T., Chen, C., Shang, M., Burridge, P. W., Epting, C. L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88574 · Cited by 149
Borkham‐Kamphorst, E., de Leur, E. V., Zimmermann, H. W., Karlmark, K. R., Tihaa, L., Haas, U., Tacke, F., Berger, T., Mak, T. W., & Weiskirchen, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.014 · Cited by 146
Karlsen, J. R., Borregaard, N., & Cowland, J. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017129 · Cited by 146
Iron-Responsive miR-485-3p Regulates Cellular Iron Homeostasis by Targeting Ferroportin
Sangokoya, C., Doss, J. F., & Chi, J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003408 · Cited by 142
Sánchez, M., Galy, B., Schwanhaeusser, B., Blake, J., Bähr-Ivacevic, T., Beneš, V., Selbach, M., Muckenthaler, M. U., & Hentze, M. W. (2011) · Blood · doi:10.1182/blood-2011-04-343541 · Cited by 137
Zhao, B., Yang, Y., Wang, X., Chong, Z., Yin, R., Song, S.-H., Zhao, C., Li, C., Huang, H., Sun, B.-F., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1090 · Cited by 136
White, K., Lu, Y., Annis, S., Hale, A., Chau, B. N., Dahlman, J. E., Hemann, C. F., Opotowsky, A. R., Vargas, S. O., Rosas, I. O., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404511 · Cited by 133
miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation.
Schaar, D., Medina, D., Moore, D. F., Strair, R., & Ting, Y. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2008.10.002 · Cited by 133
Xue, X., Bredell, B. X., Anderson, E. R., Martin, A. S., Mays, C., Nagao‐Kitamoto, H., Huang, S., Győrffy, B., Greenson, J. K., Hardiman, K. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712946114 · Cited by 131
Iron Oxide Nanoparticles: Innovative Tool in Cancer Diagnosis and Therapy
Martinková, P., Brtnický, M., Kynický, J., & Pohanka, M. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700932 · Cited by 131
Iron-regulatory proteins: molecular biology and pathophysiological implications
Cairo, G., & Recalcati, S. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000531 · Cited by 124
Wu, L., Zhang, F., Wei, Z., Li, X., Zhao, H., Lv, H., Ge, R., Ma, H., Zhang, H., Yang, B. J., et al. (2018) · Biomaterials Science · doi:10.1039/c8bm00588e · Cited by 124
Udali, S., Guarini, P., Ruzzenente, A., Ferrarini, A., Guglielmi, A., Lotto, V., Tononi, P., Pattini, P., Moruzzi, S., Campagnaro, T., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0077-1 · Cited by 123
Macrophage iron homeostasis and polarization in the context of cancer
Jung, M., Mertens, C., & Brüne, B. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.09.011 · Cited by 122
Wang, Y., Zhang, J., Su, Y., Shen, Y., Jiang, D., Hou, Y., Geng, M., Ding, J., & Chen, Y. (2017) · Nature Communications · doi:10.1038/s41467-017-00350-9 · Cited by 120
Self-citationDecreased Ferroportin Promotes Myeloma Cell Growth and Osteoclast Differentiation
Gu, Z., Wang, H., Xia, J., Yang, Y., Jin, Z., Xu, H., Shi, J., Domenico, I. D., Tricot, G. J. K., & Zhan, F. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3804 · Cited by 114
miR-20a regulates expression of the iron exporter ferroportin in lung cancer
Babu, K. R., & Muckenthaler, M. U. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1362-3 · Cited by 113
Han, M., Xu, R., Wang, S., Yang, N., Ni, S., Zhang, Q. H., Xu, Y., Zhang, X., Zhang, C., Wei, Y., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.04.002 · Cited by 113
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy
Candido, S., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., Fitzgerald, T. L., Martelli, A. M., Cocco, L., Montalto, G., Cervello, M., Polesel, J., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.08.010 · Cited by 112
Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications
Vela, D., & Vela‐Gaxha, Z. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.273 · Cited by 111
Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer
Zhou, L., Zhao, B., Zhang, L., Wang, S., Dong, D., Lv, H., & Shang, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051545 · Cited by 109
JARID1 Histone Demethylases: Emerging Targets in Cancer
Harmeyer, K. M., Facompre, N. D., Herlyn, M., & Basu, D. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.08.004 · Cited by 104
Andolfo, I., Falco, L. D., Asci, R., Russo, R., Colucci, S., Gorrese, M., Zollo, M., & Iolascon, A. (2010) · Haematologica · doi:10.3324/haematol.2009.020685 · Cited by 103
A FTH1 gene:pseudogene:microRNA network regulates tumorigenesis in prostate cancer
Chan, J. J., Kwok, Z. H., Chew, X. H., Zhang, B., Liu, C., Soong, T. W., Yang, H. H., & Tay, Y. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1248 · Cited by 103
MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis
Kindrat, I., Tryndyak, V., de Conti, A., Shpyleva, S., Mudalige, T., Kobets, T., Еrstenyuk, H. M., Beland, F. A., & Pogribny, I. P. (2015) · Oncotarget · doi:10.18632/oncotarget.6004 · Cited by 100
Wilson, S. P., Fan, L., Sahgal, N., Qi, J., & Filipp, F. V. (2017) · Oncotarget · doi:10.18632/oncotarget.15681 · Cited by 100
Wang, B., Zhang, J., Song, F., Tian, M., Shi, B., Jiang, H., Xu, W., Wang, H., Zhou, M., Pan, X., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.006 · Cited by 99
Bajbouj, K., Shafarin, J., & Hamad, M. A. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818764470 · Cited by 99
Zheng, X.-C., Ren, W., Zhang, S., Zhong, T., Duan, X.-C., Yin, Y.-F., Xu, M., Hao, Y., Li, Z.-T., Li, H., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s157082 · Cited by 98
Ferrosenescence: The iron age of neurodegeneration?
Sfera, A., Bullock, K., Price, A. I., Inderias, L., & Osorio, C. P. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.11.012 · Cited by 96
Knickle, A. F., Fernando, W., Greenshields, A. L., Rupasinghe, H. P. V., & Hoskin, D. W. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.05.005 · Cited by 96
Local iron homeostasis in the breast ductal carcinoma microenvironment
Marques, O., Porto, G., Rêma, A., Faria, F., Cruz Paula, A., Gomez-Lazaro, M., Silva, P., Martins da Silva, B., & Lopes, C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2228-y · Cited by 90
SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1
Jeong, S. M., Lee, J. J., Finley, L. W. S., Schmidt, P. J., Fleming, M. D., & Haigis, M. C. (2014) · Oncogene · doi:10.1038/onc.2014.124 · Cited by 90
An important role of the hepcidin–ferroportin signaling in affecting tumor growth and metastasis
Guo, W., Zhang, S., Chen, Y., Zhang, D., Yuan, L., Cong, H., & Liu, S. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv063 · Cited by 90
Self-citationLipopolysaccharides Upregulate Hepcidin in Neuron via Microglia and the IL-6/STAT3 Signaling Pathway
Qian, Z.-M., He, X., Liang, T., Wu, K.-C., Yan, Y.-C., Lu, L.-N., Yang, G., Luo, Q. Q., Yung, W.-H., & Ke, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8671-3 · Cited by 89
Tsai, S., Huang, P., Hsu, Y., Peng, Y., Lee, C., Wang, J., Chen, J., & Lin, S. (2016) · Scientific Reports · doi:10.1038/srep28612 · Cited by 88
Eyvazzadeh, N., Shakeri‐Zadeh, A., Fekrazad, R., Amini, E., Ghaznavi, H., & Kamrava, S. K. (2017) · Lasers in Medical Science · doi:10.1007/s10103-017-2267-x · Cited by 88
Micromanaging Iron Homeostasis
Yoshioka, Y., Kosaka, N., Ochiya, T., & Kato, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356717 · Cited by 86
The role of iron in tumour cell proliferation
Steegmann-Olmedillas, J. L. (2011) · Clinical and Translational Oncology · doi:10.1007/s12094-011-0621-1 · Cited by 84
Mertens, C., Akam, E. A., Rehwald, C., Brüne, B., Tomat, E., & Jung, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166164 · Cited by 83
Lipper, C. H., Karmi, O., Sohn, Y. S., Darash‐Yahana, M., Lammert, H., Song, L., Liu, A. W. K., Mittler, R., Nechushtai, R., Onuchic, J. N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715842115 · Cited by 83
15. IRON AND ITS ROLE IN CANCER DEFENSE: A DOUBLE-EDGED SWORD
Thévenod, F. (2018) · Metallo-Drugs: Development and Action of Anticancer Agents · doi:10.1515/9783110470734-015 · Cited by 82
The mechanism of ageing: primary role of transposable elements in genome disintegration
Sturm, Á., Ivics, Z., & Vellai, T. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1896-0 · Cited by 81
Bourseau-Guilmain, E., Griveau, A., Benoît, J., & Garcion, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025515 · Cited by 81
Iron metabolism: State of the art
Daher, R., & Karim, Z. (2017) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2017.06.015 · Cited by 80
Truffi, M., Colombo, M., Sorrentino, L., Pandolfi, L., Mazzucchelli, S., Pappalardo, F., Pacini, C., Allevi, R., Bonizzi, A., Corsi, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24968-x · Cited by 79
Fillebeen, C., Wilkinson, N., Charlebois, E., Katsarou, A., Wagner, J., & Pantopoulos, K. (2018) · Blood · doi:10.1182/blood-2018-03-841197 · Cited by 78
Kuo, K.-T., Huang, W.-C., Bamodu, O. A., Lee, W., Wang, C., Hsiao, M., Wang, L.-S., & Yeh, C. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0533-9 · Cited by 76
The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers
Tury, S., Assayag, F., Bonin, F., Château‐Joubert, S., Servely, J., Vacher, S., Becette, V., Caly, M., Rapinat, A., Gentien, D., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5104 · Cited by 72
Ferritin iron regulators, PCBP1 and NCOA4, respond to cellular iron status in developing red cells
Ryu, M., Duck, K. A., & Philpott, C. C. (2017) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2017.09.009 · Cited by 71
Nielsen, M. J., Andersen, C. B. F., & Moestrup, S. K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.471060 · Cited by 69
Horniblow, R. D., Bedford, M., Hollingworth, R., Evans, S. C., Sutton, E., Lal, N., Beggs, A. D., Iqbal, T. H., & Tselepis, C. (2017) · Cancer Science · doi:10.1111/cas.13234 · Cited by 69
Chakka, L. R. J., Chellappan, D. R., Bhavsar, D. V., Ranganathan, R., Banudevi, S., Subramanian, A., Sharma, U., Jagannathan, N. R., Krishnan, U. M., & Sethuraman, S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.053 · Cited by 68
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3
Pasricha, S., Lim, P. J., Duarte, T. L., Casu, C., Oosterhuis, D., Mleczko‐Sanecka, K., Suciu, M., da Silva, A. R., Al-Hourani, K., Arezes, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00500-z · Cited by 68
Deng, Z., Manz, D. H., Torti, S. V., & Torti, F. M. (2017) · Oncotarget · doi:10.18632/oncotarget.19288 · Cited by 67
Blanchette-Farra, N., Kita, D., Konstorum, A., Tesfay, L., Lemler, D. J., Hegde, P., Claffey, K. P., Torti, F. M., & Torti, S. V. (2018) · Oncogene · doi:10.1038/s41388-018-0243-y · Cited by 67
Kaomongkolgit, R., Cheepsunthorn, P., Pavasant, P., & Sanchavanakit, N. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.08.005 · Cited by 65
Liu, N. Q., Marchi, T. D., Timmermans, A. M., Beekhof, R., Trapman-Jansen, A., Foekens, R., Look, M. P., van Deurzen, C. H. M., Span, P. N., Sweep, F. C. G. J., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.037176 · Cited by 65
Molecular regulation of cellular iron balance
Recalcati, S., Gammella, E., Buratti, P., & Cairo, G. (2017) · IUBMB Life · doi:10.1002/iub.1628 · Cited by 64
Ren, X., Chen, Y., Peng, H., Fang, X., Zhang, X., Chen, Q., Wang, X., Yang, W., & Sha, X. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b10167 · Cited by 63
Self-citationColucci, S., Pagani, A., Pettinato, M., Artuso, I., Nai, A., Camaschella, C., & Silvestri, L. (2017) · Blood · doi:10.1182/blood-2017-04-780692 · Cited by 62 · cited 1×
“Whereas the immunophilin FKBP12 represses hepcidin expression by binding the BMP type I receptor ALK2 and blocking BMP-SMAD pathway in hepatoma cells [162].”
BackgroundmiR-214 Regulates Lactoferrin Expression and Pro-Apoptotic Function in Mammary Epithelial Cells ,
Liao, Y., Du, X., & Lönnerdal, B. L. (2010) · Journal of Nutrition · doi:10.3945/jn.110.124289 · Cited by 62
A role for STEAP2 in prostate cancer progression
Whiteland, H., Spencer-Harty, S., Morgan, C., Kynaston, H., Thomas, D. H., Bose, P., Fenn, N. J., Lewis, P., Jenkins, S. A., & Doak, S. H. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9679-9 · Cited by 62
Cascella, B., & Mirica, L. M. (2012) · Biochemistry · doi:10.1021/bi3012466 · Cited by 62
Ohba, C., Nabatame, S., Iijima, Y., Nishiyama, K., Tsurusaki, Y., Nakashima, M., Miyake, N., Tanaka, F., Ozono, K., Saitsu, H., et al. (2014) · Journal of Human Genetics · doi:10.1038/jhg.2014.18 · Cited by 60
Song, E., Ramos, S. V., Huang, X., Liu, Y., Botta, A. M., Sung, H. K., Turnbull, P. C., Wheeler, M. B., Berger, T., Wilson, D. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720570115 · Cited by 60
The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin
Huang, X., Borgström, B., Stegmayr, J., Abassi, Y., Kruszyk, M. M., Leffler, H., Persson, L., Albinsson, S., Massoumi, R., Scheblykin, I. G., et al. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00257 · Cited by 60
Miyazawa, M., Bogdan, A. R., Hashimoto, K., & Tsuji, Y. (2018) · RNA · doi:10.1261/rna.063941.117 · Cited by 59
Shan, Z., Wei, Z., & Shaikh, Z. A. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.07.017 · Cited by 59
Tamanaha, E., Guan, S., Marks, K., & Saleh, L. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b03243 · Cited by 58
A mechanistic overview of TET-mediated 5-methylcytosine oxidation
Ponnaluri, V. K. C., Maciejewski, J. P., & Mukherji, M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.077 · Cited by 57
Disordered signaling governing ferroportin transcription favors breast cancer growth
Chen, Y., Zhang, S., Wang, X., Guo, W., Wang, L., Zhang, D., Yuan, L., Zhang, Z., Xu, Y., & Liu, S. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.002 · Cited by 57
Self-citationJohansen, C., Bertelsen, T., Ljungberg, C., Mose, M., & Iversen, L. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.04.012 · Cited by 57
Calcium is an essential cofactor for metal efflux by the ferroportin transporter family
Deshpande, C. N., Ruwe, T. A., Shawki, A., Xin, V., Vieth, K. R., Valore, E. V., Qiao, B., Ganz, T., Nemeth, E., Mackenzie, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05446-4 · Cited by 57
Zhou, Q., Chen, J., Feng, J., & Wang, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1001-3 · Cited by 57
Menezes, S. V., Sahni, S., Kovačević, Ž., & Richardson, D. R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.776393 · Cited by 54
Decreased expression of ferroportin in prostate cancer
Xue, D., Zhou, C., Shi, Y., Lü, H., & He, X. (2015) · Oncology Letters · doi:10.3892/ol.2015.3363 · Cited by 53
Human lactoferrin attenuates the proinflammatory response of neonatal monocyte-derived macrophages
Wisgrill, L., Wessely, I., Spittler, A., Förster‐Waldl, E., Berger, A., & Sadeghi, K. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13108 · Cited by 53
Pro-metastatic collagen lysyl hydroxylase dimer assemblies stabilized by Fe2+-binding
Guo, H., Tsai, C.-L., Terajima, M., Tan, X., Banerjee, P., Miller, M. D., Liu, X., Jiang, Y. L., Byemerwa, J. K., Alvarado, S. K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02859-z · Cited by 52
Self-citationLi, P., Zheng, X., Shou, K., Niu, Y., Jian, C., Zhao, Y., Yi, W., Hu, X., & Yu, A. (2016) · PubMed · Cited by 52
Kontoghiorghes, G. J. (2008) · Hemoglobin · doi:10.1080/03630260701726533 · Cited by 49
Zip14 expression induced by lipopolysaccharides in macrophages attenuates inflammatory response
Sayadi, A., Nguyen, A.-T., Bard, F., & Bard-Chapeau, E. A. (2012) · Inflammation Research · doi:10.1007/s00011-012-0559-y · Cited by 49
Wang, L., Mao, Y., Du, G., He, C., & Han, S. (2015) · Tumor Biology · doi:10.1007/s13277-014-2859-z · Cited by 48
Tumor associated macrophages deliver iron to tumor cells via Lcn2.
Duan, X., He, K., Li, J., Cheng, M. S., Song, H., Liu, J., & Liu, P. (2018) · Europe PMC (PubMed Central) · Cited by 48
Arezes, J., Costa, M., Vieira, I. H., Dias, V., Kong, X. L., Fernandes, R., Vos, M. R. J., Carlsson, A., Rikers, Y. G. M., Porto, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079870 · Cited by 47
Targeting STEAP1 Protein in Human Cancer: Current Trends and Future Challenges
Barroca-Ferreira, J., Pais, J. P., Santos, M. M. M., Gonçalves, A. M., Gomes, I. M., Sousa, I., Rocha, S. M., Passarinha, L. A., & Maia, C. J. (2017) · Current Cancer Drug Targets · doi:10.2174/1568009617666170427103732 · Cited by 46
Lin, R., Huang, J., Wang, L., Li, Y., Lipowska, M., Wu, H. C., Yang, J., & Mao, H. Z. (2018) · Biomaterials Science · doi:10.1039/c8bm00225h · Cited by 46
STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells
Burnell, S. E. A., Spencer-Harty, S., Howarth, S., Bodger, O. G., Kynaston, H., Morgan, C., & Doak, S. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-24655-x · Cited by 46
Liu, Y., Chen, Z., Gu, N., & Wang, J. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.05.1031 · Cited by 45
Cao, L., Liu, H., Yue, Z., Liu, L., Pei, L., Gu, J.-X., Wang, H., & Jia, M. (2018) · BioMetals · doi:10.1007/s10534-018-0123-5 · Cited by 45
Neshasteh‐Riz, A., Khosravi, Z., Ghaznavi, H., & Shakeri‐Zadeh, A. (2018) · Radiation and Environmental Biophysics · doi:10.1007/s00411-018-0754-5 · Cited by 45
Jiang, X., & Elliott, R. L. (2017) · Anticancer Research · doi:10.21873/anticanres.11567 · Cited by 44
Inhibition of prostate cancer proliferation by Deferiprone
Simoes, R. V., Veeraperumal, S., Serganova, I. S., Kruchevsky, N., Varshavsky, J., Blasberg, R. G., Ackerstaff, E., & Koutcher, J. A. (2017) · NMR in Biomedicine · doi:10.1002/nbm.3712 · Cited by 42
Liao, Y., & Lönnerdal, B. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.019 · Cited by 40
Increased expression of HIF2α during iron deficiency–associated megakaryocytic differentiation
Jimenez, K., Khare, V., Evstatiev, R., Kulnigg‐Dabsch, S., Jambrich, M., Strobl, H., & Gasché, C. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12884 · Cited by 40
Moussa, R., Park, K. C., Kovačević, Ž., & Richardson, D. R. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.027 · Cited by 40
Shinoda, S., Kaino, S., Amano, S., Harima, H., Matsumoto, T., Fujisawa, K., Takami, T., Yamamoto, N., Yamasaki, T., & Sakaida, I. (2018) · Oncotarget · doi:10.18632/oncotarget.25421 · Cited by 40
Chen, M., Chou, C.-H., Shun, C., Mao, T., Wen, W.-F., Chen, C., Chen, S., Yang, Y., & Ho, H. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox099 · Cited by 39
Tong, W.-H., Maio, N., Zhang, D., Palmieri, E. M., Ollivierre, H., Ghosh, M. C., McVicar, D. W., & Rouault, T. A. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018015669 · Cited by 36
Huang, T., Sun, Y., Li, Y., Wang, T., Fu, Y., Li, C., & Li, C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4928703 · Cited by 36
15. Iron and Its Role in Cancer Defense: A Double-Edged Sword
Thévenod, F. (2018) · De Gruyter eBooks · doi:10.1515/9783110470734-021 · Cited by 35
Iron participated in breast cancer chemoresistance by reinforcing IL-6 paracrine loop
Li, J., He, K., Liu, P., & Xu, L. X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.064 · Cited by 34
Du, F., Qian, Z., Gong, Q., Zhu, Z. J., Lü, L., & Ke, Y. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.12.002 · Cited by 33
STEAP1 Regulates Tumorigenesis and Chemoresistance During Peritoneal Metastasis of Gastric Cancer
Wu, Y., Jiang, J., Fang, X., & Ji, F. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01132 · Cited by 32
Tao, Y., Wu, Q., Guo, X., Zhang, Z., Shen, Y., & Wang, F. (2014) · British Journal of Haematology · doi:10.1111/bjh.12863 · Cited by 31
Pyle, C., Azad, A., Papp, A., Sadee, W., Knoell, D., & Schlesinger, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112375 · Cited by 31
Song, A., Eo, W. K., Kim, S., Shim, B., & Lee, S. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2240-7 · Cited by 31
Efficacy and safety of deferasirox in myelodysplastic syndromes
Breccia, M., & Alimena, G. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1703-7 · Cited by 30
Iron-heme-Bach1 axis is involved in erythroblast adaptation to iron deficiency
Kobayashi, M., Kato, H., Hada, H., Itoh‐Nakadai, A., Fujiwara, T., Muto, A., Inoguchi, Y., Ichiyanagi, K., Hojo, W., Tomosugi, N., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.151043 · Cited by 29
Hamilton, J. L., Hatef, A., ul‐haq, M. I., Nair, N., Unniappan, S., & Kizhakkedathu, J. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109880 · Cited by 28
Shpyleva, S., Pogribna, M., Cozart, C. R., Bryant, M., Muskhelishvili, L., Tryndyak, V., Ross, S. A., Beland, F. A., & Pogribny, I. P. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.06.012 · Cited by 28
Anti-tumor activities of four chelating agents against human neuroblastoma cells.
Langtao, S., Zhao, H.-Y., Du, J., & Wang, F. (2005) · PubMed · Cited by 27
Guaraldo, M., Santambrogio, P., Rovelli, E., Savino, A. D., Saglio, G. N., Cittaro, D., Roetto, A., & Levi, S. (2016) · Scientific Reports · doi:10.1038/srep33432 · Cited by 25
Lin, H., Wang, Y., Lai, H., Li, X., & Chen, T. (2018) · Chemistry - An Asian Journal · doi:10.1002/asia.201800862 · Cited by 25
Self-citationEpigenetic role for the conserved Fe-S cluster biogenesis protein AtDRE2 in Arabidopsis thaliana
Buzas, D. M., Nakamura, M., & Kinoshita, T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404058111 · Cited by 24
Zuo, E., Lu, Y., Yan, M., Pan, X., & Cheng, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.7574 · Cited by 24
Jeong, J., Kwon, E.-K., Cheong, T.-C., Park, H., Cho, N., & Kim, W. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am500661j · Cited by 23
Meng, F., Zhen, S., & Song, B. (2017) · Apmis · doi:10.1111/apm.12704 · Cited by 23
HDAC1 governs iron homeostasis independent of histone deacetylation in iron-overload murine models
Yin, X., Wu, Q., Monga, J., Xie, E., Wang, H., Wang, S., Zhang, H., Wang, Z.-Y., Zhou, T., Shi, Y., et al. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7161 · Cited by 22
Yang, J. D., Xu, T., Gomez, D. R., Yuan, X., Nguyen, Q., Jeter, M. D., Song, Y., Komaki, R. U., Hu, Y., Hahn, S. M., et al. (2018) · Cancer Medicine · doi:10.1002/cam4.1349 · Cited by 22
Ryan, B. J., Pelt, D. W. V., Guth, L. M., Ludzki, A. C., Gioscia‐Ryan, R. A., Ahn, C., Foug, K. L., & Horowitz, J. F. (2018) · Experimental Physiology · doi:10.1113/ep087283 · Cited by 22
Chang, Y.-C., Lo, W.-J., Huang, Y., Lin, C.-L., Feng, C.-C., Lin, H.-T., Cheng, H., & Yeh, S. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1280604 · Cited by 20
Bian, Z., HANN, H.-W. L., Ye, Z., Yin, C., Wang, Y., Fang, W., Wan, S., Wang, C., & Tao, K. (2018) · Oncology Letters · doi:10.3892/ol.2018.9099 · Cited by 19
Self-citationViktorínová, A. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.07.022 · Cited by 19
MUB40 Binds to Lactoferrin and Stands as a Specific Neutrophil Marker
Anderson, M. C., Chaze, T., Coïc, Y., Injarabian, L., Jönsson, F., Lombion, N., Selimoglu‐Buet, D., Souphron, J., Ridley, C. E., Vonaesch, P., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.01.014 · Cited by 18
The regulation of iron metabolism in the mononuclear phagocyte system
Kong, W.-N., Lei, Y., & Chang, Y. (2013) · Expert Review of Hematology · doi:10.1586/17474086.2013.814840 · Cited by 17
Methods for Studying Iron Regulatory Protein 1: An Important Protein in Human Iron Metabolism
Holmes‐Hampton, G. P., Ghosh, M. C., & Rouault, T. A. (2017) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.09.006 · Cited by 13
Saito, K., Fujiwara, T., Ota, U., Hatta, S., Ichikawa, S., Kobayashi, M., Okitsu, Y., Fukuhara, N., Onishi, Y., Ishizuka, M., et al. (2017) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2017.07.006 · Cited by 12
Ikeda, R., Vermeulen, L. C., Jiang, Z., Lau, E., & Kolesar, J. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2010.130 · Cited by 10
NGAL promotes recruitment of tumor infiltrating leukocytes
Pacifico, F., Pisa, L., Mellone, S., Cillo, M., Lepore, A., & Leonardi, A. (2018) · OncoTarget · doi:10.18632/oncotarget.25625 · Cited by 9
Lisowska‐Myjak, B., Skarżyńska, E., Wilczyńska, P., & Jakimiuk, A. J. (2017) · BioMetals · doi:10.1007/s10534-017-0073-3 · Cited by 7
Research works printed but not linked: 13
- Sahni, 2014, NDRG1 as a molecular target to inhibit the epithelial-mesenchymal transition: The case for developing inhibitors of metastasis, Future Med. Chem., 6, 1241, 10.4155/fmc.14.80 · doi:10.4155/fmc.14.80
- Wang, 2018, The MYB/miR-130a/NDRG2 axis modulates tumor proliferation and metastatic potential in salivary adenoid cystic carcinoma, Cell Death Dis., 9, 917, 10.1038/s41419-018-0966-2 · doi:10.1038/s41419-018-0966-2
- Yang, 2018, NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway, Int. J. Biochem. Cell Boil., 99, 43, 10.1016/j.biocel.2018.03.003 · DOI
- Chen, 2018, Potential role of NDRG2 in reprogramming cancer metabolism and epithelial-to-mesenchymal transition, Histol. Histopathol., 33, 655
- Zhang, A., Wang, B., Yang, M., Shi, H., and Gan, W. (2015). beta2-microglobulin induces epithelial-mesenchymal transition in human renal proximal tubule epithelial cells in vitro. BMC Nephrol., 16. · doi:10.1186/s12882-015-0057-x
- Koh, 2015, HGF mediated upregulation of lipocalin 2 regulates MMP9 through nuclear factor-kappaB activation, Oncol. Rep., 34, 2179, 10.3892/or.2015.4189 · DOI
- Arosio, 2014, New signaling pathways for hepcidin regulation, Blood, 123, 1433, 10.1182/blood-2014-01-548594 · DOI
- Barteselli, 2015, Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature, BioMed Res. Int., 2015, 249617
- Piro, 2018, Sustained Erythroid Response in a Patient with Myelofibrosis Receiving Concomitant Treatment with Ruxolitinib and Deferasirox, Chemotherapy, 63, 107, 10.1159/000486822 · doi:10.1159/000486822
- Fu, 2017, IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy, Int. J. Nanomed., 12, 3751, 10.2147/IJN.S113963 · doi:10.2147/ijn.s113963
- Tsai, 2018, Tuning the Distance of Rattle-Shaped IONP@Shell-in-Shell Nanoparticles for Magnetically-Targeted Photothermal Therapy in the Second Near-Infrared Window, ACS Appl. Mater. Interfaces, 10, 1508, 10.1021/acsami.7b14593 · doi:10.1021/acsami.7b14593
- Liu, 2010, The immunotherapeutic effect of Fe3O4 nanoparticles as adjuvants on mice H22 live cancer, J. Nanosci. Nanotechnol., 10, 514, 10.1166/jnn.2010.1591 · doi:10.1166/jnn.2010.1591
- Jin, 2010, Influence of magnetic Fe3O4 nanoparticle on functions of lymphocytes and macrophages in mice, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 18, 136
Cited by
Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer
Wang, W., Lu, K., Jiang, X., Wei, Q., Zhu, L., Wang, X., Jin, H., & Feng, L. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02720-2 · Cited by 300
Iron Metabolism and Immune Regulation
Ni, S., Yuan, Y., Kuang, Y., & Li, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.816282 · Cited by 259
Rusu, I. G., Suharoschi, R., Vodnar, D. C., Pop, C. R., Socaci, S. A., Vulturar, R., Istrati, M., Moroșan, I., Fărcaș, A. C., Kerezsi, A. D., et al. (2020) · Nutrients · doi:10.3390/nu12071993 · Cited by 185
The Multifaceted Role of Heme in Cancer
Fiorito, V., Chiabrando, D., Petrillo, S., Bertino, F., & Tolosano, E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01540 · Cited by 129
Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma
Yao, F., Cui, X., Zhang, Y., Bei, Z., Wang, H., Zhao, D., Wang, H., & Yang, Y. (2021) · Oncology Letters · doi:10.3892/ol.2021.12918 · Cited by 75
Metadata
- Authors
- Wang, Y., Yu, L., Ding, J., & Chen, Y.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-12-27
- Volume
- 20
- Issue
- 1
- Pages
- 95
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2907110005
- Cited by
- 294
- References
- 186
- FWCI
- 15.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.